Issue 6/1997
Content (20 Articles)
Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury
T. Soulis, V. Thallas, S. Youssef, R. E. Gilbert, B. G. McWilliam, R. P. Murray-McIntosh, M. E. Cooper
Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine
H. P. Hammes, A. Bartmann, L. Engel, P. Wülfroth
Immunostimulation increases the resistance of mouse embryos to the teratogenic effect of diabetes mellitus
A. Torchinsky, V. Toder, S. Savion, J. Shepshelovich, H. Orenstein, A. Fein
Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2
H. Rothe, R. M. O'Hara, S. Martin, H. Kolb
Relationships between plasma measures of oxidative stress and metabolic control in NIDDM
J. Nourooz-Zadeh, A. Rahimi, J. Tajaddini-Sarmadi, H. Tritschler, P. Rosen, B. Halliwell, D. J. Betteridge
Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM
C. G. Monciotti, A. Semplicini, A. Morocutti, M. Maioli, M. R. Cipollina, I. Barzon, C. Palaro, E. Brocco, M. Trevisan, P. Fioretto, G. Crepaldi, R. Nosadini
Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells
N. Takahara, A. Kashiwagi, Y. Nishio, N. Harada, H. Kojima, H. Maegawa, H. Hidaka, R. Kikkawa
Genetic studies of neuropeptide Y and neuropeptide Y receptors Y1 and Y5 regions in morbid obesity
C. Roche, P. Boutin, C. Dina, G. Gyapay, A. Basdevant, J. Hager, B. Guy-Grand, K. Clément, P. Froguel
Glucose tolerance and mortality, including a substudy of tolbutamide treatment
W. C. Knowler, G. Sartor, A. Melander, B. Scherstén
Renal function and insulin resistance as determinants of plasma leptin levels in patients with NIDDM
T. Shoji, Y. Nishizawa, M. Emoto, K. Maekawa, Y. Hiura, S. Tanaka, T. Kawagishi, Y. Okuno, H. Morii
Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance
S. Del Prato, M. Matsuda, D. C. Simonson, L. C. Groop, P. Sheehan, F. Leonetti, R. C. Bonadonna, R. A. DeFronzo
Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study
M. Greaves, R. G. Malia, K. Goodfellow, M. Mattock, L. K. Stevens, J. M. Stephenson, J. H. Fuller, Complications Study Group EURODIAB IDDM
Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men
K. Yamada, X. Yuan, S. Ishiyama, K. Koyama, F. Ichikawa, A. Koyanagi, W. Koyama, K. Nonaka
24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients
P. L. Poulsen, E. Ebbehøj, K. W. Hansen, C. E. Mogensen
Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men
S. M. Haffner, H. Miettinen, M. P. Stern
Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes
H. Sone, Y. Kawakami, Y. Okuda, Y. Sekine, S. Honmura, K. Matsuo, T. Segawa, H. Suzuki, K. Yamashita
Prevention of IDDM: strategies based on new observations of molecular pathogenesis Workshop held in Majvik, Kirkkonummi, Finland, 6–8 May 1996
H. K. Åkerblom, M. Knip